Literature DB >> 9664830

Utilization characteristics of health care service for rheumatoid arthritis patients in Korea.

K J Cho1, S H Jang, S K Lee, W S Doh.   

Abstract

The purpose of this study was to determine the factors which were responsible for delaying early diagnosis and optimal management of rheumatoid arthritis (RA) in Korea. We interviewed 109 outpatients diagnosed as RA being treated by rheumatologists, and we eventually analyzed 98 patients' data. The median length of time from symptom onset to the first visit to a medical doctor, to diagnosis, and visiting a rheumatologist were 8 weeks, 23 weeks, and 42 months respectively. The subspecialist with whom the patients consulted with for the longest time before visiting a rheumatologist were an orthopaedic surgeon for 51 patients, a Chinese herbal doctor for 19 patients, and a pharmacist for 16 patients. For early diagnosis and optimal management of RA in Korea, we believe that it is necessary to reduce the use of unconventional medical services such as Chinese herbal medicine and nonprescribed medication, and to emphasize rheumatologic and rehabilitative care in the early stage.

Entities:  

Mesh:

Year:  1998        PMID: 9664830     DOI: 10.3349/ymj.1998.39.3.247

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  3 in total

1.  Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea.

Authors:  Hyun Ah Kim; Yeong-Il Seo
Journal:  Rheumatol Int       Date:  2003-03-27       Impact factor: 2.631

2.  From Symptoms to Diagnosis: An Observational Study of the Journey of Rheumatoid Arthritis Patients in Saudi Arabia.

Authors:  Waleed Hussain; Abdulsalam Noorwali; Nahid Janoudi; Maatouqa Baamer; Lina Kebbi; Hanady Mansafi; Ashraf Ibrahim; Shereen Gohary; Joan Minguet; Hani Almoallim
Journal:  Oman Med J       Date:  2016-01

Review 3.  The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.

Authors:  Alaa S Barhamain; Rami F Magliah; Mohammad H Shaheen; Shurooq F Munassar; Ayman M Falemban; Mohammed M Alshareef; Hani M Almoallim
Journal:  Open Access Rheumatol       Date:  2017-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.